Skip to content
Screener

Tandem Diabetes Care TNDM Other Income (Expense)

Other Income (Expense) at other companies

Insulet logo
InsuletPODD
-$1.1M-185%
Medtronic logo
MedtronicMDT
$137M
Beta Bionics logo
Beta BionicsBBNX
$2.18M-27.6%
Embecta Corp. logo
Embecta Corp.EMBC
$2.8M-41.7%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$82K+383%
Abbott logo
AbbottABT
$134M-2.2%

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.56B+128%
Enterprise value$2.23B+109%
P/S1.5×+0.8×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income and other income, net1,225(632)4,8513,561
Interest expense(2,450)(1,905)(4,654)(3,767)
Loss from equity method investment(5,641)(3,375)(9,506)(6,917)
Total other income (expense), net(6,866)(5,912)(9,309)(7,123)
Loss before income taxes(20,658)(57,722)(40,535)(179,811)
Income tax expense (benefit)510(5,322)1,0263,145
Net loss$(21,168)$(52,400)$(41,561)$(182,956)
Other comprehensive income (loss):

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's other income (expense)?
Tandem Diabetes Care (TNDM) reported other income (expense) of -$6.87M in Q2 2026.
How has Tandem Diabetes Care's other income (expense) changed year-over-year?
Tandem Diabetes Care's other income (expense) decreased by 16.1% year-over-year, from -$5.91M to -$6.87M.
What is the long-term trend for Tandem Diabetes Care's other income (expense)?
Over 3 years (2021 to 2025), Tandem Diabetes Care's other income (expense) has grown at a 24.5% compound annual growth rate (CAGR), from -$6.75M to -$13.02M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Tandem Diabetes Care's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude